Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

Those hoping the Court of Appeals for the Federal Circuit would finally resolve priority in the long-pending dispute between the University ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

Aera Therapeutics shifts focus to lipid nanoparticles for T-cell targeting therapy while continuing work on protein nanoparticles. CEO Akin Akinc leads development for autoimmune diseases.

China-born biologist Zhang Feng has been awarded the United States ... work developing the revolutionary gene-editing tool CRISPR-Cas9. According to the citation from the US Patent and Trademark ...

"Our study is a first step in dramatically expanding our repertoire of effective and safe CRISPR-Cas9 enzymes. In our manuscript, we demonstrate the utility of these PAMmla-predicted enzymes to ...

Rebecca Buckley, David Robinson II and Feng Zhang will be recognized Sunday in Wallace Wade Stadium. Their professional backgrounds span from medical research to legal counsel.